Caveat emptor when it comes to hormone therapy for menopause, Elizabeth Tracey reports

Podcast: Download (Duration: 1:15 — 1.7MB)

Subscribe: RSS

Hormone therapy for menopause has recently had a black box warning removed by the FDA, after the agency reexamined data originally prompting the warning and found it flawed. Wen Shen, a menopause expert at Johns Hopkins, says women still need to be cautious when it comes to deciding whether hormone therapy will fit their needs. 

Shen: Now there's all those Internet sites that sell hormone therapy to women. These commercial ventures, when they were getting started these sites they will pay for any kind of medical providers. You can be a dentist, then if there are side effects and complications of course they don't follow up any complications then falls to that woman's GYN.   :28

Shen advocates for getting information from reputable websites that use an evidence based approach and seeing a clinician who has expertise in the field of menopause medicine, emphasizing that when it comes to using hormones, one size does not fit all. At Johns Hopkins, I’m Elizabeth Tracey.